Flumazenil for benzodiazepine sedation reversal — ORE Part 1 MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Give intravenous flumazenil and continue respiratory support
Explanation lettering: D = shown as A · A = shown as B · E = shown as D · B = shown as E
B is correct. Persistent respiratory depression following midazolam, despite basic airway measures and oxygen, requires continued airway and ventilatory support plus intravenous flumazenil, the specific benzodiazepine antagonist. Flumazenil reverses benzodiazepine sedation and may restore spontaneous respiration, but observation must continue because re-sedation and recurrent respiratory depression can occur. The added exclusions make clinically important contraindication scenarios, such as chronic benzodiazepine exposure, benzodiazepine-treated epilepsy and mixed overdose, unlikely. A would worsen benzodiazepine-induced respiratory depression. C is neither an antidote nor suitable for an acute respiratory emergency. D is used for selected hypoglycaemic emergencies or beta-blocker toxicity, not benzodiazepine reversal. E is unsafe because respiratory depression has persisted despite initial support.
Reference: Electronic Medicines Compendium. Flumazenil 100 micrograms/ml solution for injection/infusion: Summary of Product Characteristics, sections 4.1, 4.2 and 4.4, 2022. https://www.medicines.org.uk/emc/product/6300/smpc